Cha et al. used CD68 and CD163 to detect CLS (n = 140), reported that CLS status had no impact on the prognosis of breast cancer upon univariate analysis, but did report that CD68-detected CLS were associated with shorter overall survival in node-positive breast cancer patients [126]. The gene discussed is CD68; the disease is breast carcinoma.